Global Antisense and RNAi Therapeutics

Topics: RNA, Medicine, DNA Pages: 4 (435 words) Published: November 10, 2014
Global Antisense and RNAi Therapeutics Market 2015-2019

Antisense and RNAi therapeutics are new innovative therapeutic options that can be used for the treatment of serious chronic and rare diseases. RNAi is an RNA-based gene silencing process in which RNA molecules inhibit gene expression by destroying specific mRNA molecules. Antisense technology involves the synthesis of a strand of nucleic acid that would bind to the disease-causing mRNA. It binds to the mRNA or to a splicing site on the pre-mRNA and inactivates it effectively.

RNAi and antisense are two of the predominant technologies used by pharmaceutical companies, research institutes, and others for various applications in research, diagnostics, and therapeutics. RNAi therapeutics offers a wide scope in the treatment of diseases such as cancer and neurodegenerative diseases. Two types of RNA molecules are used in RNAi technology: miRNA and siRNA. RNAi molecules bind to other specific RNAs in the cell, such as mRNA, to manage their activity to treat the RNA-mediated disorder. Covered in this Report

This report covers the present scenario and the growth prospects of the Global Antisense and RNAi Therapeutics market for the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of antisense and RNAi therapeutics used for the treatment of various chronic diseases including: Infectious diseases

Cardiovascular diseases
Kidney diseases
Cancer
Metabolic disorders
Others

View our full TOC here

Key Regions

EMEA
APAC
Americas

Key Vendors

Alnylam Pharmaceuticals
Isis Pharmaceuticals
Sanofi SA
Tekmira Pharmaceuticals

Other Prominent Vendors

Acuitas Therapeutics
Allergan
Antisense Therapeutics
Ascletis
AstraZeneca
Atlantic Pharmaceuticals
Benitec Biopharma
Biogen Idec
Bristol-Myers Squibb
Dainippon Sumitomo Pharma
Dicerna Pharmaceuticals
Enzon Pharmaceuticals
F. Hoffmann-La Roche
GlaxoSmithKline
Gradalis...
Continue Reading

Please join StudyMode to read the full document

You May Also Find These Documents Helpful

  • Rnai Essay
  • Global Peptide Therapeutics Market 2014-2018 Essay
  • Global Overactive Bladder Therapeutics Market 2014-2018 Essay
  • Essay on RNAi screening and gene knockdown
  • Antisense therapy Essay
  • Global Issues Essay
  • Global Management Essay
  • global warming Essay

Become a StudyMode Member

Sign Up - It's Free